IL-1 gene expression in human mammary tumour xenografts after treatment with hexadecylphosphocholine.
Safa
O
O
Department of Biomedical Sciences, University of Bradford, UK.
Parkin
S M
SM
Bibby
M C
MC
D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000473:pathology; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014183:Transplantation, Heterologous
D015703:Antigens, CD; D000970:Antineoplastic Agents; D007375:Interleukin-1; D010767:Phosphorylcholine; C039128:miltefosine; D003520:Cyclophosphamide